apollo
0
Written By Santoshini Reddy G , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Nov 23, 2024 | 4:27 PM IST

Hexiplat 50 mg Injection 25 ml is used to treat Colon and rectal cancer. It contains Oxaliplatin, which works by killing the cancer cells. Thereby, it helps treat cancer. Sometimes, Hexiplat 50 mg Injection 25 ml may cause side effects such as mild nausea, vomiting, diarrhoea, fever, and headache. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy and breastfeeding.

Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Composition

OXALIPLATIN-2MG

Manufacturer/Marketer

Hilfen Pharmaceuticals Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

for this medicine

About Hexiplat 50 mg Injection 25 ml

Hexiplat 50 mg Injection 25 ml belongs to the group of medicines called platinum-containing antineoplastic agents used alone or in combination with other anti-cancer medicines to treat cancer of the large bowel/intestine (advanced colon or colorectal cancer).

Hexiplat 50 mg Injection 25 ml contains Oxaliplatin, which works by killing the cancer cells. Thereby, it helps treat cancer.

In some cases, Hexiplat 50 mg Injection 25 ml may cause side effects such as mild nausea, vomiting, diarrhoea, fever, and headache. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Do not use Hexiplat 50 mg Injection 25 ml if you are breastfeeding. Consult a doctor immediately if you become pregnant during treatment with Hexiplat 50 mg Injection 25 ml. This medicine is not recommended for children as safety and effectiveness have not been established. Inform your doctor about your health condition and medications to rule out any side effects/interactions.

Uses of Hexiplat 50 mg Injection 25 ml

Treatment of Colon and rectal cancer

Medicinal Benefits

Hexiplat 50 mg Injection 25 ml contains Oxaliplatin, which belongs to the group of medicines called platinum-containing antineoplastic agents used to treat stage III colon cancer after complete removal of the primary tumour and metastatic cancer of the colon and rectum. It is used in combination with other anti-cancer medicines, such as 5-fluorouracil and folinic acid. Hexiplat 50 mg Injection 25 ml works by killing the cancer cells. Thereby, it helps treat cancer. Hexiplat 50 mg Injection 25 ml may also be used with other medicines to prevent colon cancer from spreading in patients who have had surgery to remove the tumour.

Directions for Use

Hexiplat 50 mg Injection 25 ml will be administered by a qualified physician; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Hexiplat 50 mg Injection 25 ml

  • Mild nausea
  • Vomiting
  • Diarrhoea
  • Headache
  • Peripheral neuropathy
  • Fatigue
  • Back pain
  • Stomach pain

Drug Warnings

Do not use Hexiplat 50 mg Injection 25 ml if you are allergic to any of its components, if you are breastfeeding, have a low blood cell count, have severe kidney problems, tingling and numbness in the fingers/toes, and have difficulty performing fragile tasks, such as buttoning clothes. Inform the doctor if you ever suffered an allergic reaction to platinum-containing medicines, have mild/moderate kidney problems, liver problems or abnormal liver function tests during therapy, or heart disorders like prolongation of the QT interval (abnormal electrical signal), an irregular heartbeat, or a family history of heart problems. Seek immediate medical attention if you experience symptoms of an allergic reaction (rash, itching, hives, reddening of the skin, hoarseness, difficulty breathing or swallowing, feeling as if your throat is closing, dizziness, swelling of the lips and tongue, lightheadedness, or fainting), unpleasant sensation in the throat, rhabdomyolysis (muscle pain and swelling), nerve problems (sensitivity to cold temperature or cold objects, pain, tingling or burning sensation), Posterior Reversible Encephalopathy Syndrome (headache, confusion, seizures, vision problems), myelosuppression (chills or shivering, burning or pain on urination, pain on swallowing, sore throat, cough with mucus, persistent diarrhoea), lung problems (shortness of breath, wheezing, cough), or bleeding problems (vomit that looks like coffee grounds or bloody vomit, pink or brown urine, weakness, dizziness, changes in speech, confusion, unexplained bleeding or dark-coloured/tarry stools).

Drug Interactions

Drug-Drug Interactions: Inform the doctor if you are taking medicines that prolong QT interval (antiarrhythmic agents), nephrotoxic products, or anti-coagulants.

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform the doctor if you have an infection, lung, liver or kidney problems, bleeding problems, heart problems (long QT syndrome, irregular/slow heartbeat), or changes in electrolyte levels.

Habit Forming

No

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include vegetables and fruits in your diet.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugar.
  • Get optimal sleep; rest well.
  • Drink enough water and eat fibre-rich foods, vegetables and fruits.

Special Advise

  • Women must use reliable contraception during treatment and for nine months after receiving the last dose.
  • Male patients are advised not to father a child during treatment and for six months after the last dose. Use effective contraception during this time.
  • If you are due to undergo any surgery, including dental surgery, inform the doctor/dentist that you are on treatment with Hexiplat 50 mg Injection 25 ml.
  • Avoid eating or drinking anything that is colder than room temperature for five days after receiving each dose of Hexiplat 50 mg Injection 25 ml. To reduce side effects caused by cold temperature-cover yourself with a blanket while getting treatment with Hexiplat 50 mg Injection 25 ml, wear warm clothing in cold weather at all times, cover your mouth and nose with a scarf and wear gloves whilst touching cold objects. Drink fluid at room/warm temperature and always drink through a straw. Avoid using ice and AC, touching cold metals, and breathing deeply when exposed to cold air.

Disease/Condition Glossary

Colon and rectal cancer: It is a cancer of the colon or rectum. Colorectal cancer is the growth of cells that form in the lower end of the digestive tract. Most of these cancers begin as polyps (non-cancerous growths). Symptoms may include abdominal discomfort, blood in the stool, and changes in bowel habits like constipation or diarrhoea.

bannner image

Alcohol

Consult your doctor

It is not known if alcohol affects Hexiplat 50 mg Injection 25 ml. Please consult your doctor.

bannner image

Pregnancy

Unsafe

Hexiplat 50 mg Injection 25 ml may cause foetal harm. Therefore, avoid becoming pregnant during treatment with Hexiplat 50 mg Injection 25 ml.

bannner image

Breast Feeding

Unsafe

Breastfeeding is not recommended during treatment with Hexiplat 50 mg Injection 25 ml and for three months after the last dose.

bannner image

Driving

Caution

Hexiplat 50 mg Injection 25 ml may cause dizziness or vision problems. Avoid driving or operating machinery if you experience any side effects that might lessen your ability to do so.

bannner image

Liver

Consult your doctor

If you have a history of liver disease, inform your doctor before receiving Hexiplat 50 mg Injection 25 ml.

bannner image

Kidney

Caution

Hexiplat 50 mg Injection 25 ml should not be used if you have severe kidney disease. If you have mild or moderate kidney disease, inform your doctor before receiving Hexiplat 50 mg Injection 25 ml.

bannner image

Children

Unsafe

Hexiplat 50 mg Injection 25 ml is not recommended for children as safety and effectiveness have not been established.

Country of origin

India

Manufacturer/Marketer address

Office No. 102, Shah Prima Plot No. 13, Sector 2, Kharghar, Navi Mumbai,Raigarh,Maharashtra-410210
Other Info - HEX0216

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Hexiplat 50 mg Injection 25 ml is used to treat Colon and rectal cancer.
Hexiplat 50 mg Injection 25 ml works by killing the cancer cells. Thereby, it helps treat cancer.
Hexiplat 50 mg Injection 25 ml may have an anti-fertility effect, which could be irreversible. Therefore, male patients should seek medical advice on the conservation of sperm prior to treatment with Hexiplat 50 mg Injection 25 ml.
Avoid drinking or eating anything colder than room temperature. Do not touch any cold objects, wash your hands in cold water, go near air conditioners or freezers, or go outside in cold weather unless absolutely necessary for five days after you receive each dose of Hexiplat 50 mg Injection 25 ml. Wear a hat, gloves, and a scarf, and cover your mouth and nose if you must go outside in cold weather.
Hexiplat 50 mg Injection 25 ml may decrease the ability to fight infections due to reduced white blood cells. Stay away from sick people during treatment with Hexiplat 50 mg Injection 25 ml.
Hexiplat 50 mg Injection 25 ml is administered to you through an intravenous (IV) infusion. A healthcare professional usually gives it in a clinical setting.
The common side effects of Hexiplat 50 mg Injection 25 ml are mild nausea, vomiting, diarrhoea, headache, peripheral neuropathy, fatigue, back pain, and stomach pain. However, these symptoms vanish as your body adjusts to the medication. If these symptoms become worse, please consult a doctor for relief.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.